Enhanced Implant Delivery System with Synchronized Catheter Steering

An improved implant delivery system featuring synchronized steering of multiple catheters, enabling enhanced control, flexibility, and stability during cardiac valve repair procedures.

The original patent described a controlled steering functionality for an implant-delivery tool, addressing the need for precise navigation in cardiac valve repair procedures. However, this invention had limitations in terms of control and flexibility. The new inventive concept builds upon the original patent, overcoming these limitations by introducing synchronized steering of multiple catheters, thereby providing enhanced control, flexibility, and stability during implant delivery.

The enhanced implant delivery system comprises a first catheter with a steerable distal end portion and a proximal portion, and a second catheter with a steerable distal end portion and a proximal portion. The second catheter is configured to advance through the lumen of the first catheter. The steerable distal end portions of both catheters are designed to rotate in tandem, providing enhanced control during delivery. Alternatively, the steerable distal end portions can rotate independently, offering enhanced flexibility during delivery. Additionally, the system can be configured to rotate the steerable distal end portions in a synchronized manner, ensuring enhanced stability during delivery. This innovative system enables precise navigation and control during cardiac valve repair procedures, reducing the risk of complications and improving patient outcomes.

The new claims introduce the concept of synchronized steering of multiple catheters, which is not present in the original patent. This innovation provides a significant improvement in control, flexibility, and stability during implant delivery, making it a non-obvious advancement over the prior art.

Alternative embodiments of the inventive concept could include the use of additional catheters, different steering mechanisms, or varying degrees of synchronization. These variations would enable the system to adapt to different clinical scenarios and patient needs, ensuring broad conceptual coverage.

The enhanced implant delivery system has significant commercial potential in the cardiac valve repair market, which is projected to grow substantially in the coming years. The system's improved control, flexibility, and stability make it an attractive solution for medical device manufacturers and clinicians, potentially leading to increased adoption and market share.